Vaccine Info

Vaqta Hepatitis A

VAQTA is indicated for the prevention of disease caused by hepatitis A virus (HAV) in persons 12 months of age and older.

The primary dose should be given at least 2 weeks prior to expected exposure to HAV.

Hepatitis A virus has a relatively long incubation period (approximately 20 to 50 days). VAQTA may not prevent hepatitis A infection in individuals who have an unrecognized hepatitis A infection at the time of vaccination.

Updated
April 30th, 2019